Search Results
Results found for "Owen P. McGuinness"
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
M., Medel-Lacruz, B., Baidya, M., Makarova, M., Mistry, R., Goulding, J., Drube, J., Hoffmann, C., Owen Toxicol. 52, 179–197. https://doi.org/10. 1146/annurev.pharmtox.010909.105800 Tsao, P.
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
The fission yeast Schizosaccharomyces pombe has two mating types, Plus (P) and Minus (M). Here, we investigated the stringency of the two GPCRs, Mam2 and Map3, for their respective pheromones, P-factor
- Overview of adhesion GPCRs self-activation
clearly demonstrate part of the molecular mechanisms involved in the self-activation of aGPCRs and open Embo j, 2012. 31(6): p. 1364-78. 2. Xiao, P., et al., Tethered peptide activation mechanism of the adhesion GPCRs ADGRG2 and ADGRG4. Nature, 2022. 604(7907): p. 628-630. 7.
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L. T. (2016).
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
The activation process begins with the α-helical domain (AHD) of the G protein in an open state, which As GTP stabilizes and migrates towards the P loop, it causes the TCAT motif to shift, a key movement provided by the cryo-EM study offers a clear view of these dynamic states, from an inactive state (open
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
. -11.6 placebo, p<0.0001) at Week 5 (Cohen’s d effect size of 0.61).
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
Associated with Huntington Disease "Highly Statistically Significant Reduction in Chorea Movements (p
- Glyco-sulfo hotspots in the chemokine receptor system
2016) where O-glycosylation contributes to the differential binding to CC or CX3C chemokine (Casarosa P sites in their N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P glycosulfo peptide analogue GSnP-6 displays nanomolar affinity and promising potential for blocking PSGL-1/P-selectin
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Premium Sneak Peak: Human Substance P–NK1R interactions observed by NMR; Endocrine Metabolic GPCRs 2026 GPCR—supporting open resources while giving members deeper insight and earlier visibility.
- Conjugation Strategies for Probe Development
biomolecules or induce cell toxicity. [ 5] At Celtarys’ we have our conjugation strategy - our own (2) Sam, S.; Touahir, L.; Salvador Andresa, J.; Allongue, P.; Chazalviel, J.
- 📰 GPCR Weekly News, May 22 to 28, 2023
Bryan Roth, Peter Gmeiner, and Thomas P. Sakmar this week. For Dr.
- Decoding β-Arrestins: from Structure to function
bioinformatics tools offer the potential to explore larger portions of the β-arrestin interactome (Crépieux, P. with overlapping sites may experience mutually exclusive binding due to steric hindrance (Crépieux, P.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
coupling between extracellular and transmembrane domains modulates holo-adhesion GPCR function Szymon P
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
receptors, data mapper, structure similarity search and models of physiological ligand complexes Luis P
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
and TM7 on the other hand, form possible dimerization interfaces (Ploier, B. et al. 2016; Dijkman, P.
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
-P., Macdonald, C. B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A. M., Trinidad, D.
- 📰 GPCR Weekly News, November 13 to 19, 2023
challenge in the Dahl SS rat GPCRs in Neuroscience Neurokinin-2 receptor negatively modulates substance P
- 📰 GPCR Weekly News, April 24 to 30, 2023
Thomas P. Sakmar, Debbie L. Hay, Lukas Grätz, and more.
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
They also showed higher protein levels of phospho-glycogen synthase kinase-3β (p-GSK3β), as well as total
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
Beth is also the hiring manager for their open Principal Scientist, In Vitro Pharmacology role posted I keep an open door and you’ll find me among the team in the lab quite often. There’s comradery and open exchange in our team and I strive to provide learning opportunities for career
- How GPCR Spatial Signaling Sparked a Scientific Journey
But the moment I designed my own experiment, I was hooked. Yet that summer research placement cracked open a new reality: the thrill of asking questions no one By 2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute But luck only works if you say yes when the door opens. By understanding how signaling is organized in time and space, her team is opening doors to next-generation
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Structural explanation of the receptor binding mechanism of a highly potent antagonist analog Isaikina, P.
- Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?
In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
Now, Terry is opening the vault. This isn’t theory.
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Yamina’s Corner opens for strategic consulting, and our partner Celtarys unveils a robust TR-FRET assay Dr.GPCR Updates Terry’s Corner is Live - Pharmacology at your fingertips Terry’s Corner is now open!
- Understanding the Journey: Catherine Demery's Path to Addiction Science
For Catherine Demery, it meant rewriting everything on her own terms. It was really, really fascinating… and just eye opening to a part of the world that I don’t think I would Catherine's decision to defer pharmacy school was a leap of faith that opened new doors. It is essential to remain open to new experiences and to trust your instincts.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Advances in biased signaling, allosterism, and endosomal signaling have opened new therapeutic frontiers
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
GPCR ecosystem , Celtarys is opening up that model to the broader research community. The goal?
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Career opportunities: New openings for a postdoctoral research position in GPCR biochemistry and biophysics missed opportunities: Discover how to identify and target cryptic intracellular allosteric sites, opening the success of its first volume, the research topic "GPCRs: Signal Transduction: Volume II" is now open
















